Search - tctmd.com

Displaying 121 - 140 of 1107

Sort: Relevancy | Date

Presentation THT 2025

Navigating Conduction Abnormalities Following Transcatheter Tricuspid Valve Replacement (TTVR): A Single Center Experience

Presenter: Tooba Salar

February 12, 2025

Presentation THT 2025

Lower Extremity Lymphatic Flow Is Associated With Diuretic Response and Weight Change (Decongestion) in Acute Heart Failure

Presenter: Jan Biegus

February 12, 2025

Presentation THT 2025

Limited Myocardial Necrosis With Intracoronary Supersaturated Oxygen Therapy in Acute Anterior Myocardial Infarction: Initial Experience in Routine Practice

Presenter: Andreas Schafer

February 12, 2025

Presentation THT 2025

Leveraging Remote Patient Monitoring to Optimize Guideline-Directed Medical Therapy in Heart Failure With Reduced Ejection Fraction

Presenter: Qianlan Xi

February 12, 2025

Presentation THT 2025

Introduction of Guideline Directed Medical Therapy (GDMT) in Acute Myocardial Infarction (AMI) Shock Patients Supported by Impella 5.5

Presenter: Kanika Mody

February 12, 2025

Presentation THT 2025

Initial Experience of Cardiogenic Shock Team Approach Management at a Tertiary-Level Hospital in Mexico

Presenter: Renata Quevedo-Salazar

February 12, 2025

Presentation THT 2025

Impact of Sitagliptin on Long-Term Outcomes in Heart Failure With Reduced Ejection Fraction in Type 2 Diabetes Patients: A Retrospective Cohort Study

Presenter: Thitiphan Srikulmontri

February 12, 2025

Presentation THT 2025

Impact of LV Unloading Strategy on Clinical Outcomes of Patients Supported With VA-ECMO from the Cardiogenic Shock Working Group

Presenter: Kevin John

February 12, 2025

Presentation THT 2025

Impact of HF Pharmacological Therapy on the Durability of Favorable Response After LVAD Weaning: A VAD Wean Registry Analysis

Presenter: Stavros Drakos

February 12, 2025

Presentation THT 2025

HF Etiology and the Sustainability of Favorable Response After LVAD Weaning: A VAD Wean Registry Analysis

Presenter: Stavros Drakos

February 12, 2025

Presentation THT 2025

Heart Transplantation Outcomes in Older Adults: A Single-Center Experience

Presenter: Neha Panigrahy

February 12, 2025

Presentation THT 2025

Healthcare Professionals' Perspectives on the Treatment of Systemic Inflammation With Heart Failure and Associated Patient Journey Mapping

Presenter: Marat Fudim

February 12, 2025

Presentation THT 2025

Handheld Ultrasound Reliably Measures Placement of Impella® Devices

Presenter: Miguel Woodham

February 12, 2025

Presentation THT 2025

Gender Disparities in the Association of Low Dietary Protein Intake With Congestive Heart Failure: An Analysis of the NHANES Database 2017-2020

Presenter: Phuuwadith Wattanachayakul

February 12, 2025

Presentation THT 2025

ECG-Based Deep Learning Algorithm for Risk Stratification of Left Ventricular Systolic Dysfunction: A Retrospective Single-Center Study

Presenter: Neil Keshvani

February 12, 2025

Presentation THT 2025

Congestive Cardiac Failure Mortality in the United States: Trends and Disparities From 1999 to 2020

Presenter: Sherif Eltawansy

February 12, 2025

Presentation THT 2025

Comparative Outcomes of Temporary Mechanical Circulatory Support in Acute Myocardial Infarction-Related Cardiogenic Shock

Presenter: Qianlan Xi

February 12, 2025

Presentation THT 2025

Clinical Outcomes Among Patients With HFpEF and Peripheral Arterial Disease Undergoing Revascularization

Presenter: Phuuwadith Wattanachayakul

February 12, 2025

Presentation THT 2025

Characteristics and Outcomes of Patients Transferred to a “Hub” Center for Cardiogenic Shock

Presenter: Van-Khue Ton

February 12, 2025

Presentation THT 2025

Burst Steroid Therapy and Quality of Life in Patients With Acute Heart Failure: Insights From the CORTAHF Trial

Presenter: Matteo Pagnesi

February 12, 2025

Advertisement

Navigating Conduction Abnormalities Following Transcatheter Tricuspid Valve Replacement (TTVR): A Single Center Experience

Lower Extremity Lymphatic Flow Is Associated With Diuretic Response and Weight Change (Decongestion) in Acute Heart Failure

Limited Myocardial Necrosis With Intracoronary Supersaturated Oxygen Therapy in Acute Anterior Myocardial Infarction: Initial Experience in Routine Practice

Leveraging Remote Patient Monitoring to Optimize Guideline-Directed Medical Therapy in Heart Failure With Reduced Ejection Fraction

Introduction of Guideline Directed Medical Therapy (GDMT) in Acute Myocardial Infarction (AMI) Shock Patients Supported by Impella 5.5

Initial Experience of Cardiogenic Shock Team Approach Management at a Tertiary-Level Hospital in Mexico

Impact of Sitagliptin on Long-Term Outcomes in Heart Failure With Reduced Ejection Fraction in Type 2 Diabetes Patients: A Retrospective Cohort Study

Impact of LV Unloading Strategy on Clinical Outcomes of Patients Supported With VA-ECMO from the Cardiogenic Shock Working Group

Impact of HF Pharmacological Therapy on the Durability of Favorable Response After LVAD Weaning: A VAD Wean Registry Analysis

HF Etiology and the Sustainability of Favorable Response After LVAD Weaning: A VAD Wean Registry Analysis

Heart Transplantation Outcomes in Older Adults: A Single-Center Experience

Healthcare Professionals' Perspectives on the Treatment of Systemic Inflammation With Heart Failure and Associated Patient Journey Mapping

Handheld Ultrasound Reliably Measures Placement of Impella® Devices

Gender Disparities in the Association of Low Dietary Protein Intake With Congestive Heart Failure: An Analysis of the NHANES Database 2017-2020

ECG-Based Deep Learning Algorithm for Risk Stratification of Left Ventricular Systolic Dysfunction: A Retrospective Single-Center Study

Congestive Cardiac Failure Mortality in the United States: Trends and Disparities From 1999 to 2020

Comparative Outcomes of Temporary Mechanical Circulatory Support in Acute Myocardial Infarction-Related Cardiogenic Shock

Clinical Outcomes Among Patients With HFpEF and Peripheral Arterial Disease Undergoing Revascularization

Characteristics and Outcomes of Patients Transferred to a “Hub” Center for Cardiogenic Shock

Burst Steroid Therapy and Quality of Life in Patients With Acute Heart Failure: Insights From the CORTAHF Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content